Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jan-Pablo Kollmar

Anesthesiology Portland, OR Medical Doctor

NPI 1073923249 CMS profile 4869174

707 Sw Washington St Ste 700, Portland, OR 97205

Open in the dashboard

General payments

$1,008

26 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jan-Pablo Kollmar of Portland, OR is reported in the CMS Open Payments database as having received $1,008 across 26 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $288 10
2024 General $449 8
2023 General $129 4
2022 General $124 3
2021 General $18 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jan-Pablo Kollmar
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Jan-Pablo Kollmar were reported at $288. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Jan-Pablo Kollmar Anesthesiology median Middle half National median
2019 $0 $72 $23–$151 $163
2020 $0 $36 $17–$120 $114
2021 $18 $49 $21–$135 $132
2022 $124 $52 $22–$144 $149
2023 $129 $53 $23–$143 $160
2024 $449 $55 $25–$150 $164
2025 $288 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Edwards Lifesciences Corporation $338 9 payments
  2. Abiomed $289 6 payments
  3. Atricure, Inc. $112 6 payments
  4. Abbott Laboratories $106 1 payment
  5. Haemonetics Corporation $91 1 payment
  6. Ancora Heart, Inc. $35 1 payment
  7. Medtronic, Inc. $19 1 payment
  8. Zimmer Biomet Holdings, Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,008 26 payments
Products named General payments · program years 2021–2025
  1. MITRIS RESILIA Mitral Valve $263 7 payments
  2. Impella $251 5 payments
  3. ATRICLIP LAA EXCLUSION SYSTEM $112 6 payments
  4. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $112 6 payments
  5. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $106 1 payment
  6. TEG6s HEMOSTASIS SYSTEM $91 1 payment
  7. SAPIEN 3 Ultra RESILIA $49 1 payment
  8. AccuCinch $35 1 payment
  9. Avalus $19 1 payment
  10. SYNERGY ABLATION SYSTEM $19 1 payment
  11. Other $37 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$53,345

Medicare's payments for the services billed

Medicare patients

97

Average age 74

Services billed

371

33 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 72%
Atrial fibrillation 58%
Chronic kidney disease 40%
Diabetes 38%
Arthritis 33%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

26 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record